Replies to post #80549 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

How low is this thing going to go?

No one knows...
However, I'd be looking at the target that Dew got via using Black-Scholes calculator: $0.86. Although he refused to say this was the target where the new warrant holders can maximize their return, it certainly looks like the price will be driven down to that level and the momentum would swing this even lower. People threw piles of dung at me when I suggested that we'd see $0.70. I've been in the bathroom taking HOT shower 24/7 since then.
My job is at jeopardy now.
@wmtgreeter

[jckrdu]

HOT's real.

Prior management team pursued a flawed approach going for early EMA approval where AIM2CERV was proposed as the confirming trial to get from conditional to full approval.

New Management team is working to steer the ship in new direction, as old direction was shot down by EMA. Painful process.

Current pps of .95 still IMO contains possibility of partnering AXAL/Cervical. So, two main scenarios going forward with regard to AXAL/Cervical:

KB states in conf call that AXAL/Cervical partnership discussions are progressing in positive manner, or words to that effect. PPS would rally on that news. Or...

KB states that AXAL/Cervical is winding-down. In that case, probably a brief move lower into .80s or .70s as more selling would surface on that news, IMO. Still some folks holding believing deal for AXAL/cervical is coming. Therefore still some potential selling pressure.